Integrative single-cell transcriptomics and mendelian randomization identifies BTN3A2 as a shared protective factor in Behçet’s disease and inflammatory bowel disease - Poll - MDSpire

Integrative single-cell transcriptomics and mendelian randomization identifies BTN3A2 as a shared protective factor in Behçet’s disease and inflammatory bowel disease

  • By

  • Qinjin Dai

  • Yuelan Wu

  • Wenbo Geng

  • Mengna Li

  • Wanyun Zhang

  • Yuxian Lai

  • Pei Zhang

  • Chunjiang Zhou

  • Yinuo Wang

  • Qingfeng Cao

  • Xiang Luo

  • Yujie Lai

  • Changwei Huang

  • Peizeng Yang

  • June 24, 2026

  • 0 min

Share

Original Source(s)

Integrative single-cell transcriptomics and mendelian randomization identifies BTN3A2 as a shared protective factor in Behçet’s disease and inflammatory bowel disease

  • by Qinjin Dai, Yuelan Wu, Wenbo Geng, Mengna Li, Wanyun Zhang, Yuxian Lai, Pei Zhang, Chunjiang Zhou, Yinuo Wang, Qingfeng Cao, Xiang Luo, Yujie Lai, Changwei Huang, Peizeng Yang

  • June 24, 2026

Related Content

Environmental risk factors of inflammatory bowel disease: toward a strategy of preventative health

Disease-modifying anti-inflammatory drugs (DMAIDs): shaping the future of inflammatory bowel disease

Uncovering the therapeutic potential of anti-tuberculoid agent Isoniazid in a model of microbial-driven Crohn’s disease